Could an antibiotic protect against neurodegenerative diseases during aging?

via The Scripps Research Institute

The antibiotic minocycline increases the lifespan of aged roundworms and prevents the buildup of proteins, revealing a protective mechanism that could be exploited therapeutically to help prevent neurodegenerative diseases.

Now, scientists at Scripps Research have found that minocycline can increase the lifespan of roundworms by preventing the buildup of proteins during aging, according to a study in the open-access journal eLife reports.

Protein aggregation causes several progressive age-related brain diseases, including amyotrophic lateral sclerosis, Alzheimer’s, Parkinson’s and prion diseases. The Scripps Research study shows that minocycline prevents this buildup even in older animals with age-impaired stress-response pathways.

The number of proteins in a cell is balanced by the rate of protein manufacture and disposal, called proteostasis. As we age, proteostasis becomes impaired.

“It would be great if there were a way to enhance proteostasis and extend lifespan and health, by treating older people at the first sign of neurodegenerative symptoms or disease markers such as protein build-up,” says lead author Gregory Solis, a graduate student at Scripps Research. “In this study, we investigated whether minocycline can reduce protein aggregation and extend lifespan in animals that already have impaired proteostasis.”

The team first tested 21 different molecules known to extend lifespan in young and old Caenorhabditis elegans (C. elegans) worms. They found that all of these molecules prolonged the lives of young worms, however, the only drug that worked on the older worms was minocycline.

To find out why, the researchers looked at whether minocycline had any effect on protein aggregation in the worms. They treated young and old worms with water or minocycline and then measured two proteins, ?-synuclein and amyloid-?, which are known to build up in Parkinson’s and Alzheimer’s, respectively. Regardless of the worms’ age, those treated with minocycline had reduced aggregation of both proteins as they grew older.

The team next turned their attention to the mechanism behind this discovery. First, they looked at whether minocycline switches on stress-signaling proteins that are impaired in older worms, but they found the drug actually reduces their activity. Next, they studied whether it turns off the cell’s protein-disposal processes, but this was not its mode of action either.

When researchers used a chemical probe to see how minocycline affects the major protein-regulating molecules in the cell, it revealed that minocycline directly affects the protein-manufacturing machinery of the cell, known as the ribosome. This was true in worms, as well as in mouse and human cells.

Finally, the team used worms with increased or decreased protein-manufacturing activity and studied how this altered the effect of minocycline on protein levels and lifespan. As predicted, in mutant worms where protein manufacturing was already decreased, they found a lower dose of minocycline was needed to further reduce protein levels and extend lifespan. In worms where protein manufacturing was increased, the opposite was seen. This suggested that minocycline extends lifespan by controlling the rate of protein manufacturing at the ribosome.

“We have identified minocycline as a drug that can extend lifespan and improve protein balance in already-aging worms,” says Michael Petrascheck, PhD, senior author of the paper and associate professor at Scripps Research. “Our study reveals how minocycline prevents protein aggregation and lays the foundations for drug development efforts aimed at optimizing this already-approved drug for a range of neurodegenerative diseases.”

Learn more: Antibiotic could protect against neurodegenerative diseases during aging

 

See Also

 

The Latest on: Minocycline

[google_news title=”” keyword=”minocycline” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]

via Google News

 

The Latest on: Minocycline
  • How To Get Rid Of A Blind Pimple, According To Dermatologists
    on May 23, 2024 at 7:12 am

    Zenovia Gabriel, MD, is a dermatologist, hormonal skin expert, and founder of Dr. Zenovia Skincare. Peter Young, MD, is a dermatologist and medical director of Nurx Dermatology. Carmen Castilla, MD, ...

  • Pride and Precaution: Avoiding Meltdowns and Melanoma
    on May 22, 2024 at 10:08 am

    I've been performing at Prides as a comedian and storyteller since glitter-covered T-rexes sashayed across Jurassic drag stages.It's possible this is ...

  • The Best Pregnancy-Safe Skincare Treatments, According to Experts
    on May 13, 2024 at 8:24 pm

    These skincare products and beauty treatments are safe for mama and baby—and they *actually* work to help reduce melasma, acne, fine lines, and texture.

  • Treatment of Facial Acne
    on May 13, 2024 at 5:00 pm

    Also, higher doses of minocycline might work better than those used here. Clinicians now recognize that antibiotic-only therapy can increase resistance and has lower efficacy than combined ...

  • Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
    on May 13, 2024 at 2:22 pm

    New Drug Application for DFD-29 to treat rosacea accepted for U.S. FDA review; PDUFA goal date of November 4, 2024Totalrevenues for the first ...

  • Age-Related Macular Degeneration: Putting a Hole in Our World
    on May 10, 2024 at 12:04 pm

    Estimates show that by 2040, age-related macular degeneration may affect nearly 300 million people worldwide. And we are very limited in our ability to treat or prevent it. Here's what to know.

  • How Does Minocycline Work?
    on March 30, 2024 at 5:46 am

    Minocycline is an antibiotic medicine used to treat bacterial infections in your body. It is effective in some infections of the lungs, urinary tract, eyes and others. It kills bacteria ...

  • Minocin For Injection
    on November 26, 2021 at 6:47 pm

    Minocycline 100mg; per vial; lyophilized pwd for IV infusion after reconstitution and dilution; contains magnesium sulfate heptahydrate. Monitor blood, renal, and hepatic function periodically.

  • Minocycline - Trade Names
    on March 27, 2018 at 5:54 am

    Discover the commercial and brand names of the generic drug Minocycline. This indispensable guide is essential for healthcare professionals, patients, caregivers, and anyone seeking to understand ...

  • Cetuximab in the Treatment of Squamous Cell Carcinoma of the Head and Neck
    on November 7, 2011 at 1:46 pm

    Oral antihistamines and oral tetracyclines at high (maximal anti-inflammatory) doses (minocycline 2 × 100 mg/day, lymecycline 2 × 300 mg/day or doxycycline 2 × 100 mg/day) should be ...

via  Bing News

 

What's Your Reaction?
Don't Like it!
0
I Like it!
0
Scroll To Top